Loading clinical trials...
Loading clinical trials...
Current national guidelines recommend the use of OLGIM score to evaluate the risk of gastric cancer in patients, and close gastroscopic monitoring should be performed after OLGIM grade III/IV. However...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Shandong University
NCT04191551 · Gastric Cancer, Intestinal Metaplasia of Gastric Mucosa, and more
NCT07257796 · Intestinal Metaplasia of Gastric Mucosa, Artificial Intelligence, and more
NCT07521618 · Lung Cancer (Suspected or Confirmed), Cryoablation, and more
NCT06316882 · Gastric Cancer, Gastric (Stomach) Cancer, and more
NCT05464108 · Intestinal Metaplasia of Gastric Mucosa, Artificial Intelligence, and more
Department of Gastroenterology, QiLu Hospital, Shandong University
Jinan, Shandong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions